AnalystsMitchell S. KapoorMitchell S. Kapoor's Stock Forecasts
AnalystsMitchell S. Kapoor
Sectors:
Industries:
Analyst Ranking
Bottom 21%
#3977 out of 4989 analysts
Average Return
-1.84%
Win Rate
55%6 out of 11
Risk vs Reward
Poor
Good
Mitchell S. Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Crescent Biopharma IncCBIO | +6.98% | $12.90 | $13.80 | 2025‑08‑10 - 2025‑08‑20 | Buy |
Boundless Bio IncBOLD | +2.70% | $1.11 | $1.14 | 2025‑08‑10 - 2025‑08‑20 | Buy |
Korro Bio IncKRRO | +1.80% | $18.93 | $19.27 | 2025‑08‑12 - 2025‑08‑20 | Buy |
Lexeo Therapeutics IncLXEO | +1.69% | $4.72 | $4.80 | 2025‑08‑14 - 2025‑08‑20 | Buy |
Metagenomi IncMGX | +1.09% | $1.83 | $1.85 | 2025‑08‑18 - 2025‑08‑20 | Buy |
Mitchell S. Kapoor Analyst Color
Get additional color on Mitchell S. Kapoor's coverage of popular stocks
Mitchell S. Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Metagenomi IncMGX | 1 | Buy | $7.00 | +278.38% | Reiterates | 2 days ago |
Zura Bio LtdZURA | 1 | Hold | $2.00 | +14.29% | Maintains | 2 days ago |
Oruka Therapeutics IncORKA | 1 | Buy | $45.00 | +212.50% | Reiterates | 3 days ago |
Lexeo Therapeutics IncLXEO | 1 | Buy | $9.00 | +87.50% | Maintains | 6 days ago |
Instil Bio IncTIL | 1 | Buy | $125.00 | +393.49% | Reiterates | 6 days ago |
Editas Medicine IncEDIT | 1 | Buy | $5.00 | +87.27% | Maintains | 6 days ago |
Summit Therapeutics IncSMMT | 1 | Buy | $44.00 | +70.08% | Reiterates | 6 days ago |
Alumis IncALMS | 1 | Buy | $14.00 | +217.46% | Reiterates | 7 days ago |
Korro Bio IncKRRO | 1 | Buy | $90.00 | +367.05% | Maintains | 8 days ago |
Crescent Biopharma IncCBIO | 1 | Buy | $25.00 | +81.16% | Initiates Coverage On | 10 days ago |
Boundless Bio IncBOLD | 1 | Buy | $4.00 | +250.88% | Maintains | 10 days ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $25.00 | +144.86% | Maintains | 13 days ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.